Christoph Springfeld

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Liver Metastases

Prognostic Factors

Drug Administration

Top Venues

Function (Oxford, England)

Hepatobiliary surgery and nutrition

Clinical and translational science

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christoph Springfeld, Peter Bailey, John P Neoptolemos
ESMO 2023 pancreatic cancer guidelines signal stepwise progress. Hepatobiliary surgery and nutrition 13 (2) (2024)
Christoph Springfeld, Peter Bailey, John P Neoptolemos
ESMO 2023 pancreatic cancer guidelines signal stepwise progress. Hepatobiliary surgery and nutrition 13 (2) (2024)
Peter Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P Neoptolemos
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival. Function (Oxford, England) 4 (3) (2023)
Christoph Springfeld, Markus Wolfgang Büchler, John P Neoptolemos
Interpreting Primary End Points in Randomized Trials of Pancreatic Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P Neoptolemos
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival. Function (Oxford, England) 4 (3) (2023)
Peter Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P Neoptolemos
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival. Function (Oxford, England) 4 (3) (2023)
Peter Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P Neoptolemos
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival. Function (Oxford, England) 4 (3) (2023)
Peter Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P Neoptolemos
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival. Function (Oxford, England) 4 (3) (2023)
Nicolas Hohmann, Martin Ronald Sprick, Azaz Ahmed, Juergen Burhenne, Marietta Kirchner, Lucian Le Cornet, Markus Kratzmann, Jacek Hajda, Albrecht Stenzinger, Karen Steindorf, Stefan Delorme, Heinz-Peter Schlemmer, Sabine Riethdorf, Ron van Schaik, Klaus Pantel, Jens Thomas Siveke, Thomas Seufferlein, Dirk Jäger, Walter Emil Haefeli, Flavia Carla Meotti, Christoph Springfeld
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy. Clinical and translational science (2023)
Hans Martin Singh, Peter Bailey, Daniel Hübschmann, Anne Katrin Berger, John P Neoptolemos, Dirk Jäger, Jens Siveke, Christoph Springfeld
Poly(ADP-ribose) polymerase inhibition in pancreatic cancer. Genes, chromosomes & cancer 60 (5) (2021)